These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 16144692)

  • 1. Hypoxia-induced dedifferentiation of tumor cells--a mechanism behind heterogeneity and aggressiveness of solid tumors.
    Axelson H; Fredlund E; Ovenberger M; Landberg G; Påhlman S
    Semin Cell Dev Biol; 2005; 16(4-5):554-63. PubMed ID: 16144692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of hypoxia on the tumor phenotype: the neuroblastoma and breast cancer models.
    Holmquist L; Löfstedt T; Påhlman S
    Adv Exp Med Biol; 2006; 587():179-93. PubMed ID: 17163166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia-induced dedifferentiation in neuroblastoma cells.
    Jögi A; Øra I; Nilsson H; Poellinger L; Axelson H; Påhlman S
    Cancer Lett; 2003 Jul; 197(1-2):145-50. PubMed ID: 12880974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIF-2alpha expression in human fetal paraganglia and neuroblastoma: relation to sympathetic differentiation, glucose deficiency, and hypoxia.
    Nilsson H; Jögi A; Beckman S; Harris AL; Poellinger L; Påhlman S
    Exp Cell Res; 2005 Feb; 303(2):447-56. PubMed ID: 15652356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia alters gene expression in human neuroblastoma cells toward an immature and neural crest-like phenotype.
    Jögi A; Øra I; Nilsson H; Lindeheim A; Makino Y; Poellinger L; Axelson H; Påhlman S
    Proc Natl Acad Sci U S A; 2002 May; 99(10):7021-6. PubMed ID: 12011461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic persistence after reoxygenation of hypoxic neuroblastoma cells.
    Holmquist L; Jögi A; Påhlman S
    Int J Cancer; 2005 Aug; 116(2):218-25. PubMed ID: 15800931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia, pseudohypoxia and cellular differentiation.
    Mohlin S; Wigerup C; Jögi A; Påhlman S
    Exp Cell Res; 2017 Jul; 356(2):192-196. PubMed ID: 28284840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human neuroblastoma cells exposed to hypoxia: induction of genes associated with growth, survival, and aggressive behavior.
    Jögi A; Vallon-Christersson J; Holmquist L; Axelson H; Borg A; Påhlman S
    Exp Cell Res; 2004 May; 295(2):469-87. PubMed ID: 15093745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroblastoma as an experimental model for neuronal differentiation and hypoxia-induced tumor cell dedifferentiation.
    Edsjö A; Holmquist L; Påhlman S
    Semin Cancer Biol; 2007 Jun; 17(3):248-56. PubMed ID: 16828305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation in neuroblastoma: diffusion-limited hypoxia induces neuro-endocrine secretory protein 55 and other markers of a chromaffin phenotype.
    Hedborg F; Fischer-Colbrie R; Ostlin N; Sandstedt B; Tran MG; Maxwell PH
    PLoS One; 2010 Sep; 5(9):. PubMed ID: 20862257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recruitment of HIF-1alpha and HIF-2alpha to common target genes is differentially regulated in neuroblastoma: HIF-2alpha promotes an aggressive phenotype.
    Holmquist-Mengelbier L; Fredlund E; Löfstedt T; Noguera R; Navarro S; Nilsson H; Pietras A; Vallon-Christersson J; Borg A; Gradin K; Poellinger L; Påhlman S
    Cancer Cell; 2006 Nov; 10(5):413-23. PubMed ID: 17097563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia promotes a dedifferentiated phenotype in ductal breast carcinoma in situ.
    Helczynska K; Kronblad A; Jögi A; Nilsson E; Beckman S; Landberg G; Påhlman S
    Cancer Res; 2003 Apr; 63(7):1441-4. PubMed ID: 12670886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrative genomics reveals hypoxia inducible genes that are associated with a poor prognosis in neuroblastoma patients.
    Applebaum MA; Jha AR; Kao C; Hernandez KM; DeWane G; Salwen HR; Chlenski A; Dobratic M; Mariani CJ; Godley LA; Prabhakar N; White K; Stranger BE; Cohn SL
    Oncotarget; 2016 Nov; 7(47):76816-76826. PubMed ID: 27765905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The HIF-2α-driven pseudo-hypoxic phenotype in tumor aggressiveness, differentiation, and vascularization.
    Pietras A; Johnsson AS; Påhlman S
    Curr Top Microbiol Immunol; 2010; 345():1-20. PubMed ID: 20517717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microvesicles as mediators of intercellular communication in cancer.
    Antonyak MA; Cerione RA
    Methods Mol Biol; 2014; 1165():147-73. PubMed ID: 24839024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intermittent hypoxia regulates stem-like characteristics and differentiation of neuroblastoma cells.
    Bhaskara VK; Mohanam I; Rao JS; Mohanam S
    PLoS One; 2012; 7(2):e30905. PubMed ID: 22363512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIF-1alpha induces MXI1 by alternate promoter usage in human neuroblastoma cells.
    Löfstedt T; Fredlund E; Noguera R; Navarro S; Holmquist-Mengelbier L; Beckman S; Påhlman S; Axelson H
    Exp Cell Res; 2009 Jul; 315(11):1924-36. PubMed ID: 19254710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Artificial neural network classifier predicts neuroblastoma patients' outcome.
    Cangelosi D; Pelassa S; Morini M; Conte M; Bosco MC; Eva A; Sementa AR; Varesio L
    BMC Bioinformatics; 2016 Nov; 17(Suppl 12):347. PubMed ID: 28185577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia-induced erythropoietin expression in human neuroblastoma requires a methylation free HIF-1 binding site.
    Rössler J; Stolze I; Frede S; Freitag P; Schweigerer L; Havers W; Fandrey J
    J Cell Biochem; 2004 Sep; 93(1):153-61. PubMed ID: 15352172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. G-CSF receptor positive neuroblastoma subpopulations are enriched in chemotherapy-resistant or relapsed tumors and are highly tumorigenic.
    Hsu DM; Agarwal S; Benham A; Coarfa C; Trahan DN; Chen Z; Stowers PN; Courtney AN; Lakoma A; Barbieri E; Metelitsa LS; Gunaratne P; Kim ES; Shohet JM
    Cancer Res; 2013 Jul; 73(13):4134-46. PubMed ID: 23687340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.